Beta-blockers decrease aqueous humor formation in the ciliary processes after instillation and are very often indispensable in the treatment of glaucoma.
8)
Efflux pumps such as P-glycoprotein are believed to be a major barrier to drug delivery. Functional and molecular characterization showed the existence of P-glycoprotein in human cornea, rabbit cornea, and a rabbit corneal cell line. 9) There has, however, been little information about ophthalmic drug transporters in the cornea.
Recently, a few beta-blockers were suggested to be actively taken up by organic cation transporter in a transfected human cell line 10) and human renal brush-border membrane vesicles, 11) although many beta-blockers were thought to permeate through the cornea via passive diffusion. 12, 13) The uptake of beta-blockers by a transporter into the cornea may be useful for targeting drugs into the eye and for reducing the instilled amount. The cornea consists of five layers: the epithelium, Bowman's membrane, stroma, Descemet's membrane and endothelium. Stratified epithelial cells with tight junctions are considered to comprise the corneal penetration barrier. Kawazu et al. 13) established an in vitro cultured normal rabbit corneal epithelial cell (RCEC) system to investigate transcellular drug permeation. In our study, we characterize the transport of beta-blockers, tilisolol and timolol, through the corneal epithelium using the RCEC system. Tilisolol is a beta-blocker that showed concentration-dependent flux in the preliminary experiment. Timolol is one of the most frequently prescribed drugs for glaucoma.
MATERIALS AND METHODS
Materials and Animals FITC-dextran (FD-4, MW 4400) and 6-carboxyfluorescein (6-CF) were purchased from Sigma Chemicals (St. Louis, MO, U.S.A.). Sodium azide (NaN 3 ), 2,4-dinitrophenol (DNP), taurocholic acid sodium salt (TA), tetraethylammonium chloride (TEA), quinidine sulfate (QUI), L-carnitine hydrochloride (CAR), guanidine hydrochloride (GUA) and verapamil hydrochloride (VER) were obtained from Nacalai Tesque Inc. (Kyoto, Japan). Timolol maleate was purchased from Wako Pure Chemical Industries Ltd. (Osaka, Japan). Tilisolol was kindly supplied by Nisshin Flour Milling Co. Ltd. (Tokyo, Japan). D- [1- 14 C]-Mannitol (specific activity, 2.11 GBq/mmol) was purchased from Amersham Life Science (Buckinghamshire, U.K.). All other chemicals were commercial products of reagent grade.
Primary cultured cells were obtained from Kurabo Industries Ltd. (Osaka, Japan). Transwell-COL ® cell culture chambers (pore size 0.4 mm, diameter 12 mm, surface area 1 cm 2 ) were purchased from Costar (Bedford, MA, U.S.A.). Dulbecco's modified Eagle's medium/nutrient mixture F-12 (DMEM/F-12), fetal bovine serum (FBS) and other culture reagents were from GIBCO (Grand Island, NY, U.S.A.). Epidermal growth factor (EGF), choleratoxin (CTX), hydrocortisone (HCS) and insulin-transferrin sodium selenite media The purpose of this study is to characterize the transport of tilisolol and timolol through the corneal epithelium, which is believed to be a tight barrier of ocular drug absorption. Cultured normal rabbit corneal epithelial cells (RCEC) were used to investigate drug transport. Primary RCEC were seeded on a filter membrane of Transwell-COL ® insert coated with fibronectin and grown in Dulbecco's modified Eagle's medium/nutrient mixture F-12 with various supplements. Beta-blocker permeability through the RCEC layer was measured to assess the transcellular permeability coefficient (P transcell ) in the absence or presence of inhibitors. The transcellular permeability of tilisolol was dependent on drug concentration although timolol showed no concentration dependency. Tilisolol flux from the apical to the basal side was larger than in the opposite direction although timolol showed no direction dependency. The transcellular permeability of tilisolol from the apical to the basal side was inhibited by sodium azide, tetraethylammonium, quinidine, taurocholic acid, guanidine and carnitine. Tilisolol had an active mechanism in uptake to the corneal epithelium, probably by the organic cation transporter family, although timolol predominantly permeated via passive diffusion. This RCEC system was useful to characterize the ocular permeation mechanism of drugs.
Transport of Timolol and Tilisolol in Rabbit Corneal Epithelium
supplement (ISL) were from Sigma Chemicals. Penicillin G and streptomycin were from Wako Pure Chemical Industries Ltd. Human fibronectin was from Boehringer Mannheim GmbH (Mannheim, Germany).
Cell Culture RCECs were cultured according to the standard method reported previously. 13) RCECs were grown using DMEM/F-12 at pH 7.4. The culture medium was supplemented with 5% FBS, 10 ng/ml EGF, 100 ng/ml CTX, 5 mg/ml ISL, 500 ng/ml HCS and antibiotics (penicillin G 100 IU/mlϩstreptomycin 100 mg/ml). The Transwell-COL ® insert was pre-coated with 4.0 mg human fibronectin as the attachment factor at room temperature for 30 min. RCECs were seeded at a density of 4ϫ10 4 cells/cm 2 on the filter membrane of the Transwell-COL ® insert and cultured at 37°C under 95% air and 5% CO 2 . The culture medium was replaced every day. The barrier of the RCEC layer grown on the filter membrane was assessed by measuring transepithelial electrical resistance (TEER) with a Millicell ERS electrical resistance meter (Millipore, Bedford, MA, U.S.A.) at different time points after seeding. The integrity of the cell layer was checked at the beginning and end of permeability experiments by determining the TEER.
Permeability Study Using RCEC In the permeability study, RCECs grown on a filter membrane were washed three times with Hank's balanced salt solution (HBSS) (1.3 mM CaCl 2 , 5.0 mM KCl, 0.3 mM KH 2 PO 4 , 0.8 mM MgCl 2 , 138 mM NaCl, 0.3 mM Na 2 HPO 4 , 5.6 mM D-glucose and 10 mM HEPES for pH 7.4) and preincubated for 30 min at 37°C in a 5% CO 2 atmosphere before permeability experiments.
Drug permeability from the apical to the basal side (A-to-B) was initiated by removing all HBSS on the apical side (0.5 ml) and replacing it with HBSS containing various concentrations of drugs at 37°C. At 30, 60, 90, and 120 min, a sample (0.9 ml) was collected from the basal side (1.5 ml) and was replaced with an equal volume of HBSS. Drug permeability from the basal to the apical side (B-to-A) was also initiated by replacing with drug solution on the basolateral side, and a sample (0.3 ml) was collected from the apical side at 37°C. The samples were used for drug determination with high performance liquid chromatography (HPLC). The hydrophilic compounds used were [ 14 C] mannitol (1.85 kBq), 6-CF (50 mM), and FD-4 (50 mM). Tilisolol (50, 500, 5000 mM) and timolol (50, 500, 5000 mM) were used as models of ophthalmic beta-blockers. In order to examine the temperature effect, transport experiments for tilisolol and timolol were carried out at 4°C. Drug permeability through a filter membrane without the cell layer was also examined in the same manner.
In the permeability study with inhibitors, the cell layer was preincubated with inhibitors on both apical and basal sides for 30 min. The inhibitor was also present on both sides during the experiment. Calculation of Transcellular Permeability Coefficient The apparent permeability coefficient through overall membrane (P app , cm/s) was calculated from the slope (flux, nmol/h) of the drug amount vs. the time profile on the receiver side (P app ϭslope/3600/surface area of the layer/initial concentration on the donor side).
The permeability coefficient of drugs through the filter membrane (P filt ) was obtained from drug flux through the fibronectin-coated filter membrane. The permeability coefficient of drugs through the RCEC layer (P cell ) was calculated by Eq. (1).
Further, P cell includes the permeability coefficients via the transcellular route (P transcell ) and the paracellular route (P paracell ). P transcell was calculated by subtracting P paracell from P cell . Hydrophilic drugs mainly permeate through the paracellular route because they cannot distribute into the cell. P cell of hydrophilic drugs means P paracell . The P paracell of tilisolol and timolol was calculated from the inverse relationship between P cell and the square root of the molecular weight in hydrophilic compounds.
Drug Determination The sample of 6-CF and FD-4 was assayed using a spectrofluorophotometer (EP-770, Spectroscopic Co., Ltd., Japan; excitation and emission wavelengths; 492 and 524 nm for 6-CF; 495 and 514 nm for FD-4). Samples of [
14 C] mannitol were measured using a liquid scintillation counter (Tri-Carb ® Models 2100TR, Packard Co., Meriden, CT, U.S.A.).
Tilisolol and timolol were determined by HPLC. Samples of tilisolol and timolol (0.3 ml) were mixed with methanol (0.6 ml), including an internal standard (0.363 mM o-ethoxybenzamide for tilisolol and 0.05 mM phenacetin for timolol). The mixture was centrifuged at 12000 g for 10 min and 50 ml of supernatant was injected into an HPLC system (LC-10AD, Shimadzu Co., Ltd., Kyoto) in reverse-phase mode. The stationary phase used was a Cosmosil ® 5C 18 -MS packed column (150 mm lengthϫ4.6 mm i.d., Nacalai Tesque Inc.). A mixture of acetonitrile and 10 mM KH 2 PO 4 (85 : 15 v/v) was used as the mobile phase with a flow rate of 1.0 ml/min. Drugs were monitored with a fluorescence detector (RF-10A, Shimadzu Co. Ltd.; excitation and emission wavelengths; 315 nm and 420 nm) for tilisolol and a UV spectrophotometric detector (SPD-10A, Shimadzu Co. Ltd.; wavelength; 290 nm) for timolol.
RESULTS
Using DMEM/F-12 containing 5% FBS, supplemented with EGF, CTX, ISL, and HCS, RCEC were readily attached to the matrix and began to spread. The density of seeding was 4ϫ10 4 cells/cm 2 and led to rapid confluence. When allowed to become highly postconfluent, the cells became very tightly packed, and stratified on the membrane surface. The cells formed multilayers and had high transparency. TEER increased to the maximum around day 8 after inoculation. Peak TEER was 143.8Ϯ23.3 ohmϫcm 2 . Cultured cells appeared to be more closely approximate the morphology of in vivo corneal tissue. Table 1 shows the values of P filt , P cell , and P paracell of hydrophilic compounds and beta-blockers. The values of P filt and P cell were not significantly different between A-to-B and B-to-A directions. P filt values of hydrophilic compounds were much larger than P cell values. There was a linear relationship between the square root values of molecular weight and P cell values in hydrophilic drugs, which mainly permeate through the paracellular route. The P cell of hydrophilic drugs means P paracell . Based on this relationship, the P paracell values of betablockers were calculated from their molecular weights.
The P transcell values of tilisolol and timolol were calculated from the permeation profiles in the A-to-B direction at various concentrations (50, 500, 5000 mM) and are presented in Fig. 1 . The P transcell values of tilisolol significantly decreased with an increase of drug concentrations although timolol showed almost constant values regardless of drug concentrations. Figure 2 shows the P transcell values of tilisolol and timolol (50 mM) in different directions. The P transcell value of tilisolol in the A-to-B direction was significantly larger than that in the opposite direction (B-to-A) at 50 mM although there was no significant difference in both A-to-B and B-to-A directions at 5000 mM. Timolol showed no significant difference at 50 mM in both A-to-B and B-to-A directions.
As a result of transport experiments at 4°C, the transcellular transport of tilisolol was not detected at 4°C in the A-to-B direction although the P transcell value of timolol decreased to 12.4Ϯ1.5% (the average of at least three experimentsϮS.E.) of that at 37°C. Figure 3 shows the effect of metabolic inhibitors such as NaN 3 and DNP on the P transcell values of tilisolol and timolol (50 mM) in the A-to-B direction. NaN 3 and DNP significantly reduced the P transcell values of tilisolol. The P transcell value of timolol was not significantly influenced by NaN 3 . DNP was not used in the permeation of timolol because it influenced the assay. Figure 4 shows the effect of substrates as transporters as competitive inhibitors of P transcell values of tilisolol and timolol (50 mM) in the A-to-B direction. The P transcell values of tilisolol were significantly suppressed by TEA, TA, QUI, GUA, CAR, and VER, although TEA did not significantly inhibit the permeability of timolol.
DISCUSSION
Generally, topical application of a drug is the method of choice because of its convenience and safety for ophthalmic October 2006 2145 Table 1 . Permeability Coefficients (P filt , P cell , and P paracell ) of Hydrophilic Compounds and Beta-Blockers through Filter Membrane and RCEC Layer in Different Directions Each value represents the mean of at least 3 experiments. Experiments were carried out at the concentration of 50 mM for 6-CF, FD-4, tilisolol and timolol and 1.75 mM for 14 CMannitol (18.5 kBq) . A-to-B: Apical side to basal side direction. B-to-A: Basal side to apical side direction. a) P paracell for beta-blockers was calculated based on the relationship between the P cell values of hydrophilic compounds and molecular weights. chemotherapy. The cornea is considered to be a major pathway for ocular permeation of topically applied drugs. 2, 3) However, the outer epithelium of the cornea, which is composed of superficial layers of flat, tightly fitted squamous cells, provides the greatest resistance to drug permeation. 12) The estimated shunt resistance in the intact full-thickness cornea is 12-16 kohm ϫcm 2 for normal cornea. 14) The permeability of 14 C-mannitol, 6-CF, and FD-4 of the RCEC layer was much higher than for the whole cornea 15) because of a lower TEER in this culture system. On the other hand, the transcellular permeability of timolol and tilisolol (P transcell values) almost agreed with their permeability coefficients through an excised cornea, as reported previously 16, 17) (corneal permeability coefficient: 1.23ϫ10 Ϫ5 cm/s for timolol and 0.272ϫ10 Ϫ5 cm/s for tilisolol). This agreement indicates that beta-blockers predominantly permeate via the transcellular route across the tight cornea. Despite leakage in this model system, it is still appropriate for evaluating transcellular drug permeability. We investigated further mechanisms of transcellular transport of tilisolol and timolol across the RCEC layer.
Beta-blockers are widely used in the clinic to treat diseases related to the cardiovascular system and ocular hypertension, glaucoma.
1) They represent a family of compounds with a wide range of lipophilic properties. Tilisolol is a nonselective hydrophilic beta-blocker and reduced intraocular pressure after instillation in the rabbit eye.
18) Epithelial permeability of tilisolol was direction-and concentration-dependent, indicating the existence of specific uptake systems in apical to basal transport (Figs. 1, 2) . It was important to note that the P transcell value for tilisolol decreased much more with decreased temperature (4°C) than that for timolol because decreased temperature highly reduces the activity of active transport. The specific permeability of tilisolol in the A-to-B direction was significantly decreased by metabolic inhibitors, NaN 3 and DNP (Fig. 3) . These results showed that the uptake of tilisolol was mediated by an active transporter. Active transport is an energy-dependent process characterized by solute movement against a chemical potential gradient. In general, the permeability of various organic cations was mediated by various types of organic cation transporters (OCT) and multidrug and toxin extrusion (MATE), which is the most recently classified multidrug resistance-conferring protein family, in the liver and kidney. [19] [20] [21] [22] TEA was transported by OCT1, OCT2, OCTN1, MATE 10, 11, [20] [21] [22] [23] [24] and QUI was transported by OCT1. 25) TA was transported by a sodium-dependent bile acid transporter, 26, 27) GUA was transported by OCT1 11) and CAR was transported by OCTN2. 28) VER was a substrate for the transport by P-glycoprotein and also significantly suppressed the transport of TEA and GUA. 10, 11) Tilisolol permeability was significantly reduced by TEA, QUI, GUA, CAR and VER (Fig. 4) . These results suggested the contribution of the OCT family or MATE family to the active transport of tilisolol in the corneal epithelium. Significant decrease of tilisolol transport by TA might cause the formation of micelles or a complex with tilisolol because of its surfactant activity and negative charge, although the TA inhibition mechanism needs further clarification.
Another nonselective beta-blocker, timolol, is one of the most frequently prescribed drugs for glaucoma. The epithelial permeability of timolol was neither direction-nor concentration-dependent and was not influenced by a metabolic inhibitor, NaN 3 (Figs. 1, 2, 3) . These results showed that timolol predominantly permeated by passive diffusion. Passive diffusion is an energy-independent process characterized by solute movement in response to a chemical potential gradient. However, timolol permeability was partially influenced by temperature and VER. These results might indicate the contribution of special transport to timolol permeability in RCEC.
Thus, tilisolol showed active uptake, probably by organic cation transporter or multidrug and toxin extrusion transporter, although timolol seemed to be predominantly permeated by passive diffusion. There have been no reports about drug permeability by these cation transporters in the corneal epithelium. Further study is necessary to examine the contribution of the transporter to the corneal permeability of timolol. The RCEC system is useful to characterize the drug transport mechanism through the corneal epithelium. 
